There are around 7,500 new cases of ovarian cancer in the UK every year, and the incidence is increasing with the aging population. Pharmacists can play a vital role in early identification of symptoms, as well as providing patients with advice on treatments, side effects and lifestyle counselling.
In C+D’s latest podcast, clinical editor Naimah Callachand spoke to a C+D clinical advisory board member, Ellen Kitetere – an independent prescriber and lead pharmacist for urological and gynaecological cancers at the Royal Marsden Hospital. Ms Kitetere discusses the important role pharmacists can play in managing and supporting patients with ovarian cancer in the community.
You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching “Chemist+Druggist podcast” on your preferred Android podcast app.
See who else is on C+D’s clinical advisory board.